Renaissance Technologies's MYGN Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 379,374 shares of Myriad Genetics, Inc. (MYGN) worth $2.33 M, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Renaissance Technologies has maintained a long-term strategic position in MYGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2016, adding 1.6 M shares. Largest reduction occurred in Q4 2013, reducing 2.17 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Myriad Genetics (MYGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Myriad Genetics (MYGN) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +357,700 | Add 1650.36% | 379,374 | $6.15 |
| Q3 2025 | -426,700 | Reduce 95.17% | 21,674 | $7.23 |
| Q2 2025 | +198,600 | Add 79.51% | 448,374 | $5.31 |
| Q1 2025 | -435,100 | Reduce 63.53% | 249,774 | $8.87 |
| Q4 2024 | +319,500 | Add 87.44% | 684,874 | $13.71 |
| Q3 2024 | +365,374 | New Buy | 365,374 | $27.39 |
| Q1 2023 | -14,974 | Sold Out | 0 | $0.00 |
| Q4 2022 | -154,800 | Reduce 91.18% | 14,974 | $0.01 |
| Q3 2022 | +76,574 | Add 82.16% | 169,774 | $19.08 |
| Q2 2022 | -2,274 | Reduce 2.38% | 93,200 | $18.17 |
| Q1 2022 | +57,500 | Add 151.42% | 95,474 | $25.20 |
| Q4 2021 | -173,600 | Reduce 82.05% | 37,974 | $27.60 |
| Q3 2021 | +139,900 | Add 195.19% | 211,574 | $32.29 |
| Q2 2021 | +71,674 | New Buy | 71,674 | $30.58 |
| Q1 2021 | -49,491 | Sold Out | 0 | $0.00 |
| Q4 2020 | -58,483 | Reduce 54.16% | 49,491 | $19.78 |
| Q3 2020 | +55,974 | Add 107.64% | 107,974 | $13.04 |
| Q2 2020 | +52,000 | New Buy | 52,000 | $11.35 |
| Q1 2020 | -95,900 | Sold Out | 0 | $0.00 |
| Q4 2019 | +95,900 | New Buy | 95,900 | $27.23 |
| Q3 2018 | -36,800 | Sold Out | 0 | $0.00 |
| Q2 2018 | -178,474 | Reduce 82.91% | 36,800 | $37.36 |
| Q1 2018 | -2,005 | Reduce 0.92% | 215,274 | $29.55 |
| Q4 2017 | +57,105 | Add 35.65% | 217,279 | $34.34 |
| Q3 2017 | +160,174 | New Buy | 160,174 | $36.18 |
| Q2 2017 | -534,700 | Sold Out | 0 | $0.00 |
| Q1 2017 | -2.15 M | Reduce 80.09% | 534,700 | $19.20 |
| Q4 2016 | -245,500 | Reduce 8.37% | 2.69 M | $16.67 |
| Q3 2016 | +1.6 M | Add 120.05% | 2.93 M | $20.58 |
| Q2 2016 | +297,500 | Add 28.75% | 1.33 M | $30.60 |
| Q1 2016 | +85,200 | Add 8.97% | 1.03 M | $37.43 |
| Q4 2015 | +93,000 | Add 10.86% | 949,600 | $43.16 |
| Q3 2015 | +216,800 | Add 33.89% | 856,600 | $37.48 |
| Q2 2015 | +366,100 | Add 133.76% | 639,800 | $33.99 |
| Q1 2015 | +179,700 | Add 191.17% | 273,700 | $35.40 |
| Q4 2014 | +33,526 | Add 55.44% | 94,000 | $34.06 |
| Q3 2014 | +11,274 | Add 22.91% | 60,474 | $38.56 |
| Q2 2014 | -13,600 | Reduce 21.66% | 49,200 | $38.92 |
| Q1 2014 | -299,900 | Reduce 82.69% | 62,800 | $34.19 |
| Q4 2013 | -2.17 M | Reduce 85.69% | 362,700 | $20.98 |
| Q3 2013 | +254,657 | Add 11.17% | 2.53 M | $23.50 |
| Q2 2013 | +2.28 M | Add 0.00% | 2.28 M | $26.87 |
Renaissance Technologies's Myriad Genetics Investment FAQs
Renaissance Technologies first purchased Myriad Genetics, Inc. (MYGN) in Q2 2013, acquiring 2,279,374 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Myriad Genetics, Inc. (MYGN) for 42 quarters since Q2 2013.
Renaissance Technologies's largest addition to Myriad Genetics, Inc. (MYGN) was in Q2 2013, adding 2,279,374 shares worth $61.25 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 379,374 shares of Myriad Genetics, Inc. (MYGN), valued at approximately $2.33 M.
As of the Q4 2025 filing, Myriad Genetics, Inc. (MYGN) represents approximately 0.00% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Myriad Genetics, Inc. (MYGN) was 2,931,674 shares, as reported at the end of Q3 2016.